# Amyotrophic Lateral Sclerosis: a New Paradigm

> **NCT03073239** · — · COMPLETED · sponsor: **Conde, Bebiana, M.D.** · enrollment: 30 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **GENETIC:** ALS patients genetic characterization
- **OTHER:** ALS patients epidemiological caracterization

## Key facts

- **NCT ID:** NCT03073239
- **Lead sponsor:** Conde, Bebiana, M.D.
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2018-03
- **Final completion:** 2018-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073239, "Amyotrophic Lateral Sclerosis: a New Paradigm". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03073239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*